Nipent and asthenia Patient Reports February 13, 2012

Nipent Side Effects Report #5173268-4
Nipent side effect was reported by a Health Professional from UNITED STATES on Nov 20, 2006. Female patient, 67 years of age, weighting 163.8 lb, was diagnosed with stem cell transplant and was treated with Nipent. After drug was administered, patient experienced the following side effects: asthenia, failure to thrive, nausea . Nipent dosage: 1.7143 MG/M2 (4 MG/M2,QD X 3), INTRAVENOUS. Patient died on 10/13/2006.

Nipent Side Effects Report #4950184-1
Nipent side effect was reported by a Consumer or non-health professional from FRANCE on Mar 10, 2006. Female patient, 48 years of age, was diagnosed with hairy cell leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: anxiety , asthenia, dementia alzheimer's type, depression , muscle spasms. Nipent dosage: 0.6667 MG (20 MG, ONCE MONTHLY), INTRAVENOUS. Patient recovered.

Nipent Side Effects Report #5028311-X
Nipent side effect was reported by a Consumer or non-health professional from FRANCE on June 05, 2006. Male patient was diagnosed with hairy cell leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: aggression, asthenia, bone pain, chills, depression , hyperhidrosis, myalgia, pyrexia, rash . Nipent dosage: unknown. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #4655614-0
Nipent side effect was reported by a Health Professional from on Apr 29, 2005. Female patient, 34 years of age, weighting 121.3 lb, was diagnosed with graft versus host disease and was treated with Nipent. After drug was administered, patient experienced the following side effects: asthenia, dehydration, hepatic enzyme increased. Nipent dosage: 0.2857 MG/M2 (4 MG/M2, EVERY 2 WEEKS), INTRAVENOUS. Patient was hospitalized. Patient recovered.


Nipent Side Effects Report #5858929-3
Nipent side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 12, 2008. Male patient, 67 years of age, weighting 215.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, asthenia, blood pressure systolic decreased, cardiomegaly, chronic lymphocytic leukaemia, confusional state, cough, diarrhoea, disease progression. Nipent dosage: 4 MG/M2. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, PREDNISONE. Patient was hospitalized. Patient died on 01/26/2006.